Adjuvant 5-FU based therapy for colorectal cancer

被引：0
|
作者：
Muñoz, A [1 ]
Rubio, I [1 ]
Mañé, JM [1 ]
Barceló, JR [1 ]
Fernández, R [1 ]
Abón, G [1 ]
Fuente, N [1 ]
López-Vivanco, G [1 ]
机构：
[1] Osakidetza SVS, Barakaido, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)80682-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
249
引用
收藏
页码：S78 / S78
页数：1
相关论文
共 50 条
  • [41] Postoperative adjuvant 5-FU/cisplatin and chemoradiation with capecitabine for advanced gastric cancer
    Lee, H.
    Choi, Y.
    Hur, W.
    Kown, H.
    Kim, M.
    Jung, G.
    Choi, H-J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S526 - S526
  • [42] 5-Fluorouracil (5-FU) plus leucovorin versus 5-FU leucovorin plus interferon-A given as adjuvant chemotherapy in colon cancer
    Papacostas, P
    Stathopoulos, GP
    Malamos, NA
    Michailakis, E
    Rigatos, S
    Golematis, B
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A : 752 - 752
  • [43] Adjuvant chemotherapy of patients with primary breast cancer (PABC) by fluorouracil (5-FU)
    Hazova, TV
    Koritova, LI
    Ilyin, NV
    [J]. EUROPEAN JOURNAL OF CANCER, 1998, 34 : S32 - S32
  • [44] Combination of ZD55-MnSOD therapy with 5-FU enhances antitumor efficacy in colorectal cancer
    Zhang, Yiqun
    Qin, Xinyu
    Zhang, Yanhong
    Zhao, Lili
    Wang, Yigang
    Liu, Xinyuan
    Yao, Liqing
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2008, 134 (02) : 219 - 226
  • [45] Combination of ZD55-MnSOD therapy with 5-FU enhances antitumor efficacy in colorectal cancer
    Yiqun Zhang
    Xinyu Qin
    Yanhong Zhang
    Lili Zhao
    Yigang Wang
    Xinyuan Liu
    Liqing Yao
    [J]. Journal of Cancer Research and Clinical Oncology, 2008, 134 : 219 - 226
  • [46] PROLONGATION OF POST OPERATIVE TUMOR-FREE INTERVAL AND SURVIVAL IN COLORECTAL CANCER BY ADJUVANT BCG OR BCG + 5-FU
    MAVLIGIT, GM
    GUTTERMAN, JU
    HERSH, EM
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1976, 17 (MAR): : 240 - 240
  • [47] 5-FU resistance in colorectal cancer cells based on lncRNA CUDR mediated autophagy pathway
    Chen, Bi
    [J]. CANCER SCIENCE, 2022, 113 : 889 - 889
  • [48] Protracted infusional 5-fluorouracil (5-FU) with bolus mitomycin in 5-FU-resistant colorectal cancer
    Chester, JD
    Dent, JT
    Wilson, G
    Ride, E
    Seymour, MT
    [J]. ANNALS OF ONCOLOGY, 2000, 11 (02) : 235 - 237
  • [49] SIGNIFICANCE OF RELAPSE FOLLOWING ADJUVANT THERAPY WITH CMF OR 5-FU IN HIGH-RISK BREAST-CANCER
    CHLEBOWSKI, RT
    WEINER, JM
    LUCE, J
    HESTORFF, R
    LANG, JE
    REYNOLDS, R
    GODFREY, T
    RYDEN, VMJ
    BATEMAN, JR
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 146 - 146
  • [50] WEEKLY REGIMEN OF 5-FU VS 5-FU PLUS INTERMEDIATE DOSE FOLINIC ACID IN THE TREATMENT OF ADVANCED COLORECTAL-CANCER
    MARTONI, A
    CRICCA, A
    GUARALDI, M
    COVIZZI, M
    FARRIS, A
    PANNUTI, F
    [J]. ANTICANCER RESEARCH, 1992, 12 (03) : 607 - 612
12345